Skip to content

Brown Wants Tighter Oversight of API Outsourcing

June 28, 2011

Senator Sherrod Brown (D-OH) has called on the U.S. Food & Drug Administration (FDA) to explore tighter oversight of outsourcing of the production of active pharmaceutical ingredients (APIs) to overseas manufacturers:

The release contains the full text of a letter from Sen. Brown to FDA Commissioner Margaret Hamburg. The letter includes comments on three categories of potential “user fee” that could be assessed on US drug manufacturers and API manufacturing facilities to cover the costs of increased efforts by the FDA to monitor the quality of APIs.

Comments are closed.